| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8728116 | Gastrointestinal Endoscopy | 2018 | 23 Pages |
Abstract
EUS-FNI of STNM01 in pancreatic cancer is safe and feasible. The CHST15 reduction could predict tumor progression and OS. Injections of STNM01 during the beginning of treatment may reduce CHST15 and warrants further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Makoto MD, Miho MD, Yuko MD, Yoko MD, PhD, Tomio MD, PhD, Yasutoshi MD, PhD, Takao MD, PhD, Naohisa MD, PhD,